COA has the vision and the drive to turn Acadia from medium Pharma to Big Pharma.
All bodes very well for Neuren as a principal partner and opens up all types of possibilities/pathways for the future of course.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.86 |
Change
0.230(1.38%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $16.90 | $16.63 | $896.2K | 53.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 143 | $16.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 168 | 4 |
View Market Depth
| Last trade - 10.38am 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |